|Application:||Gene expression microarray analysis|
|Number of samples:||39|
|Release date:||Dec 1 2017|
|Last update date:||Aug 23 2018|
|Diseases:||Leukemia, Leukemia, Hairy Cell, Neoplasms|
|Dataset link||Comprehensive analysis of genomic G-quadruplex forming oligonucleotides homologous to NHEIII1 of c-MYC promoter on leukemia cell growth inhibition and c-MYC expression|
A total of 39 samples were hybridized, representing triplicates with untreated (unt) at 0h, 24h, 48h, and 72h, and three (3) oligonucleotide treatments: Pu27, Pu9-, and Pu5- at three (3) timepoints: 24h, 48h, and 72h (3+3x3x4=39). This includes: Untreated (wild type) at 0, 24, 48, and 72 hr; Treated with the Pu5- oligonucleotide sequence TGGGGAGGGTGGGGAGGGTGGTGAGGGTGGGGAGGGGGAAGG at 24, 48, and 72hr; Treated with the Pu9- oligonucleotide sequence GGGTGGGGAGGGTGGGGAAG at 24, 48, and 72hr; and Treated with the Pu27 oligonucleotide sequence TGGGGAGGGTGGGGAGGGTGGGGAAGG at 24, 48, and 72hr. The complete data matrix including control probes (49,495 data rows) is included as a Series supplementary file.